MAIA Biotechnology Inc. (MAIA)
MAIA Biotechnology Statistics
Share Statistics
MAIA Biotechnology has 30.31M shares outstanding. The number of shares has increased by 19.79% in one year.
| 30.31M |
| 19.79% |
| 3.26% |
| 5.82% |
| 21.93M |
| 298 |
| 0.12% |
Short Selling Information
The latest short interest is 360.46K, so 1.19% of the outstanding shares have been sold short.
| 360.46K |
| 1.19% |
| 1.4% |
| 2.8 |
Valuation Ratios
The PE ratio is -1.89 and the forward PE ratio is -2.53. MAIA Biotechnology's PEG ratio is 0.06.
| -1.89 |
| -2.53 |
| 0 |
| 0.8 |
| 12.09 |
| -2.8 |
| 0.06 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for MAIA Biotechnology.
| n/a |
| n/a |
| n/a |
| n/a |
Financial Position
The company has a current ratio of 2.65, with a Debt / Equity ratio of 0.
| 2.65 |
| 2.65 |
| 0 |
| n/a |
| n/a |
| -297494.91 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| n/a |
| n/a |
| n/a |
| n/a |
| $-1,788,846.15 |
| 13 |
| 0 |
| n/a |
Taxes
| -79.95K |
| 0.34% |
Stock Price Statistics
The stock price has increased by -56.46% in the last 52 weeks. The beta is 0.04, so MAIA Biotechnology's price volatility has been higher than the market average.
| 0.04 |
| -56.46% |
| 1.81 |
| 2.14 |
| 44.3 |
| 243,155 |
Balance Sheet
The company has 9.6M in cash and 0 in debt, giving a net cash position of 9.6M.
| 9.6M |
| n/a |
| n/a |
| -87.23M |
| 11.86M |
| 6.8M |
Cash Flow
In the last 12 months, operating cash flow was -15.7M and capital expenditures 0, giving a free cash flow of -15.7M.
| -15.7M |
| n/a |
| -15.7M |
| -0.71 |
Margins
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Dividends & Yields
MAIA does not appear to pay any dividends at this time.
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| n/a |
| n/a |
| n/a |
| n/a |
Scores
| -10.09 |
| 2 |